#FunctionalMedicine #WeightLoss #Tesofensine #ObesityTreatment #MetabolicHealth To view or add a comment, sign in Breakthrough from Eli Lilly: Oral GLP-1 Drug Orforglipron : Im excited to highlight this emerging therapy that carries significant implications for the treatment of obesity and type 2 diabetes
10.4.5 Selects and uses appropriate content and teaching methods to meet individual and group needs
Without validated biomarkers of efficacy, real-world results remain anecdotal at best
A personalized treatment plan should weigh your BMI, comorbidities, insurance status, and goal weight rather than defaulting to whichever drug is cheapest
If youre a VP or Director working in strategy or corporate development at a hospital, health system or provider organization, you will get a lot of value out of my community as I purpose-build the content, fireside chats, and conversations for this group